Air purifiers fail to prevent infections
Researchers in the United Kingdom have completed a three‑year trial to see whether portable air purifiers placed in elderly care home bedrooms reduce respiratory illness.
Study design and participant flow
The trial, led by a team at the University of Bristol, enrolled more than 1,000 residents across 76 care homes that met England’s Care Quality Commission “good” rating. Homes with at least 20 beds and no existing air‑purification equipment were eligible. After consent was obtained, the facilities were randomly split into two groups.
In the control arm, 592 residents in 47 homes continued with standard care, while staff recorded daily respiratory symptoms. The intervention arm placed identical HEPA‑filter units in the bedrooms of 208 consenting residents and in communal areas of 48 homes covering an additional 369 participants. Statistitians were careful to keep these groups separate in the analysis.
Results show no clear benefit
At the end of the trial, the team accessed medical records and staff absentee data. Residents with a purifier in their bedroom averaged 0.99 respiratory infections each winter, compared with 1.04 infections for those without a unit. The margin was so slight that statistical analysis deemed it indistinguishable from chance.
In communal‑area placements, a modest drop in fever and delirium was observed, but the difference did not reach significance. Staff sick‑day counts and outbreak reports were unchanged across the two groups.
One possible explanation noted by the investigators is that the devices added workload for already stretched staff. The fans, especially in winter, generated noise that some residents found disruptive, potentially affecting sleep quality.
Another concern raised was a false sense of security. The investigators observed that after the pandemic, when infection‑control measures were relaxed, respiratory illness rates rose, suggesting that reliance on air purifiers might have led to lax hygiene practices.
Related: Science lessons from Covid are being misunderstood
These findings align with earlier laboratory work that showed HEPA filters can capture airborne particles, highlighting the gap between controlled settings and real‑world implementation.
While the trial did not demonstrate a measurable health advantage, it adds to a growing body of evidence that interventions must be evaluated in the environments where they will be used, not just in idealized laboratory conditions.
Implications for care home policy
Given the modest infection rates and the substantial financial outlay, the authors argue that portable air purifiers are unlikely to be a cost‑effective strategy for preventing respiratory disease in this setting. They suggest that resources might be better directed toward proven measures such as vaccination, staff training, and consistent hand‑hygiene protocols.
The study’s authors also note that the devices could become dust‑collectors if not maintained, further diminishing any theoretical benefit. The trial’s rigorous randomized design, however, lends credibility to its conclusions despite the complexities of field work.
In comparison with past efforts to introduce technology‑based health solutions in long‑term care, this trial highlights a recurring theme: practical adoption often hinges on factors like staff workload, resident comfort, and ongoing maintenance, which can outweigh theoretical efficacy.
For policymakers, the data suggest that mandating portable HEPA units across all care homes may not yield the expected reduction in winter respiratory illnesses and could divert funds from more impactful interventions.
All data and detailed methodology are available in the JAMA Internal Medicine article titled “High‑Efficiency Particulate Air Filters to Prevent Winter Respiratory Infections in Care Homes.”
